How do ADHD medications work?

Answers from a new study in Biological Psychiatry

2013-10-16

(Press-News.org) Philadelphia, PA, October 16, 2013 – There is a swirling controversy regarding the suspicion that medications prescribed for the treatment of ADHD (attention-deficit/hyperactivity disorder) primarily act to control disruptive behavior as opposed to having primary effects on the ability to attend to the environment. Thus, there is a continued need to better understand the neural basis of ADHD medication effects.

A new study in Biological Psychiatry now provides evidence that methylphenidate and atomoxetine, two FDA-approved medications for the treatment of ADHD, both improve the brain's activation when attempting to make fine temporal distinctions, but have differential effects on performance.

Time estimation, and particularly temporal discrimination, is impaired in individuals diagnosed with ADHD. Additionally, research using imaging scans show that the brain is under-activated when they perform such cognitive tasks.

This led researchers at King's College London to evaluate and compare stimulant and non-stimulant treatments for ADHD in the way they affect performance and brain activation. They recruited twenty adolescent males with ADHD who underwent 3 imaging scans while performing a time discrimination task after receiving single doses of methylphenidate, atomoxetine, and placebo, each administered one week apart. They also compared those results with a control group of 20 healthy males.

First author Dr. Anna Smith explains their findings: "We show here that the stimulant methylphenidate acts quickly with immediate effects upon performance on a timing task we know children with ADHD find challenging. Crucially however, acute doses of either methylphenidate or the non-stimulant atomoxetine increase brain activation in the frontal lobes, typically under-recruited in children with ADHD, so that these key under-functioning frontal brain regions operate at the normal levels seen in other children."

"This exciting finding suggests that both stimulants and non-stimulants share similar mechanisms of action and are both comparable in the way they normalise the activity of important frontal brain regions in children with ADHD. This could explain why both types of drug improve behaviour in children with ADHD, namely by normalizing the reduced activity in the frontal lobes that typifies the disorder," she added.

Methylphenidate and atomoxetine are interesting drugs to compare. Methylphenidate blocks both norepinephrine and dopamine transporters, while atomoxetine blocks only the norepinephrine transporter.

On the surface, this study appears to be a comparison of the role of dopamine and norepinephrine systems in the regulation of attention. However, norepinephrine transporters also contribute to the inactivation of dopamine in the cortex. Thus, this study might be seen as comparing two drugs that potently block norepinephrine uptake, but which differ in the extent to which they raise cortical dopamine levels.

"From this perspective, it is interesting that both drugs enhanced cortical activation during temporal discrimination, but only methylphenidate improved behavior. The reason for this dissociation is unknown," said Dr. John Krystal, Editor of Biological Psychiatry. "We cannot tell whether this is related to the extent to which dopamine is raised in the cortex or whether raising dopamine levels in other brain regions is important. Nonetheless, the findings appear to suggest that methylphenidate influences ADHD-related behaviors more potently than does atomoxetine."

### The article is "Neurofunctional Effects of Methylphenidate and Atomoxetine in Boys with Attention-Deficit/Hyperactivity Disorder During Time Discrimination" by Anna Smith, Ana Cubillo, Nadia Barrett, Vincent Giampietro, Andrew Simmons, Mick Brammer, and Katya Rubia (doi: 10.1016/j.biopsych. 2013.03.030). The article appears in Biological Psychiatry, Volume 74, Issue 8 (October 15, 2013), published by Elsevier.

Notes for editors Full text of the article is available to credentialed journalists upon request; contact Rhiannon Bugno at +1 214 648 0880 or Biol.Psych@utsouthwestern.edu. Journalists wishing to interview the authors may contact Anna Smith at +44 207 848 0463 or anna.smith@kcl.ac.uk.

The authors' affiliations, and disclosures of financial and conflicts of interests are available in the article.

John H. Krystal, M.D., is Chairman of the Department of Psychiatry at the Yale University School of Medicine and a research psychiatrist at the VA Connecticut Healthcare System. His disclosures of financial and conflicts of interests are available here.

About Biological Psychiatry Biological Psychiatry is the official journal of the Society of Biological Psychiatry, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, or behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal publishes both basic and clinical contributions from all disciplines and research areas relevant to the pathophysiology and treatment of major psychiatric disorders.

The journal publishes novel results of original research which represent an important new lead or significant impact on the field, particularly those addressing genetic and environmental risk factors, neural circuitry and neurochemistry, and important new therapeutic approaches. Reviews and commentaries that focus on topics of current research and interest are also encouraged.

Biological Psychiatry is one of the most selective and highly cited journals in the field of psychiatric neuroscience. It is ranked 4th out of 135 Psychiatry titles and 13th out of 251 Neurosciences titles in the Journal Citations Reports® published by Thomson Reuters. The 2012 Impact Factor score for Biological Psychiatry is 9.247.

About Elsevier Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group PLC is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.

Media contact Rhiannon Bugno
Editorial Office
+1 214 648 0880
Biol.Psych@utsouthwestern.edu

ELSE PRESS RELEASES FROM THIS DATE:

Glowing neurons reveal networked link between brain, whiskers

2013-10-16

DURHAM, N.C. -- Human fingertips have several types of sensory neurons that are responsible for relaying touch signals to the central nervous system. Scientists have long believed these neurons followed a linear path to the brain with a "labeled-lines" structure. But new research on mouse whiskers from Duke University reveals a surprise -- at the fine scale, the sensory system's wiring diagram doesn't have a set pattern. And it's probably the case that no two people's touch sensory systems are wired exactly the same at the detailed level, according to Fan Wang, Ph.D., ...

Defining the graphene family tree

2013-10-16

Oxford, October 16, 2013 - There has been an intense research interest in all two-dimensional (2D) forms of carbon since Geim and Novoselov's discovery of graphene in 2004. But as the number of such publications rise, so does the level of inconsistency in naming the material of interest. The isolated, single-atom-thick sheet universally referred to as "graphene" may have a clear definition, but when referring to related 2D sheet-like or flake-like carbon forms, many authors have simply defined their own terms to describe their product. This has led to confusion within ...

Cuckoos impersonate hawks by matching their 'outfits'

2013-10-16

New research shows that cuckoos have striped or "barred" feathers that resemble local birds of prey, such as sparrowhawks, that may be used to frighten birds into briefly fleeing their nest in order to lay their parasitic eggs. By using the latest digital image analysis techniques, and accounting for "bird vision" - by converting images to the spectral sensitivity of birds - researchers have been able to show for the first time that the barred patterns on a cuckoo's breast may allow it to impersonate dangerous birds of prey. This might enable cuckoos to frighten other ...

Ancient Syrians favored buying local to outsourcing production

2013-10-16

An archaeologist at the University of Sheffield has found evidence that, contrary to a widely held theory, ancient Syrians made their stone tools locally instead of importing finished tools from Turkey. The discovery, newly published online in Journal of Archaeological Science, has implications for our understanding of how early cities developed in these regions and how the geographic origins of raw materials affect developing states. During the Early Bronze Age, around 5300 to 3100 years ago, blades made of chert and obsidian remained important despite the advent ...

Software uses cyborg swarm to map unknown environs

2013-10-16

Researchers from North Carolina State University have developed software that allows them to map unknown environments – such as collapsed buildings – based on the movement of a swarm of insect cyborgs, or "biobots." "We focused on how to map areas where you have little or no precise information on where each biobot is, such as a collapsed building where you can't use GPS technology," says Dr. Edgar Lobaton, an assistant professor of electrical and computer engineering at NC State and senior author of a paper on the research. "One characteristic of biobots is that their ...

Toward a urine test for detecting blood clots

2013-10-16

Detecting dangerous blood clots, which can cause life-threatening conditions such as strokes and heart attacks, leading causes of death for men and women in the U.S., has been a coveted and elusive goal. But scientists are now reporting progress in the form of a simple urine test. Their study, in which they demonstrated that the test works using laboratory mice, appears in the journal ACS Nano. Sangeeta N. Bhatia and colleagues, including lead author and Ph.D. candidate Kevin Lin and postdoctoral fellow Gabriel Kwong, point out that blood clots — clumps of platelets ...

Light triggers death switch in cancer cells

2013-10-16

Researchers at Cardiff University have created a peptide (a small piece of protein), linked to a light-responsive dye, capable of switching 'on' death pathways in cancer cells. The peptide remains inactive until exposed to external light pulses which convert it into a cell death signal. Complex mechanisms in healthy cells normally protect us from developing cancer. However, when the finely balanced networks of interactions between proteins that control such mechanisms are disturbed, uncontrolled cell growth can occur. The Cardiff team has developed a peptide-switch ...

Engine technology on the road to meeting emissions standards

2013-10-16

An engine design appearing under the hoods of many new cars and light trucks today is close to meeting the latest pollution standards that will require vehicles to emit fewer harmful particles over their lifetimes, scientists are reporting. The new study on emissions from gasoline direct injection (GDI) technology appears in the ACS journal Environmental Science & Technology. Matti Maricq and colleagues explain that to meet new regulations, vehicle manufacturers need to make cars both more fuel-efficient and less polluting, which can be a difficult engineering challenge. ...

Maximizing broccoli's cancer-fighting potential

2013-10-16

Spraying a plant hormone on broccoli — already one of the planet's most nutritious foods — boosts its cancer-fighting potential, and researchers say they have new insights on how that works. They published their findings, which could help scientists build an even better, more healthful broccoli, in ACS' Journal of Agricultural & Food Chemistry. John Juvik and colleagues explain that diet is one of the most important factors influencing a person's chances of developing cancer. One of the most helpful food families includes cruciferous vegetables, such as broccoli, kale ...

University of Toronto research warns against Wi-Fi in cars

2013-10-16

TORONTO, ON – Plans to provide high-speed Internet access in vehicles, announced last month by Canadian telecommunications company Rogers Communications and American provider Sprint Corporation, could do with some sobering second-thought, says a researcher in the Department of Psychology at the University of Toronto. "Because of the potential for driver distraction, safety should be of great concern," said Professor Ian Spence, author of a new study on the impact of auditory distractions on visual attention. "Many people assume that talking to a voice-operated device ...

How do ADHD medications work?

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: